TruScreen flags it needs to raise capital again, shortly

Kiwi cervical cancer screening device company TruScreen says it is at a "turning point" in the commercialisation of its technology, as it contemplates burgeoning sales avenues in China and Vietnam – but it needs capital urgently to achieve these goals. The NZX and ASX-listed company this morning.